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ABSTRAK 
 
 
Latar belakang: 
 
Denggi adalah sejenis penyakit sebaran nyamuk yang paling menular di dunia yang 
menjadi punca beban kesihatan awam yang besar di Wilayah Pasifik Barat. Ia adalah 
punca kematian dan morbiditi utama di Malaysia. Malaysia adalah negara endemik 
untuk denggi, di mana terdapat kesemua serotaip virus denggi (DENV-1, DENV-2, 
DENV-3, DENV-4). Walau bagaimanapun, serotaip utama berubah dari tahun ke tahun 
dan juga di berbeza antara negeri-negeri di Malaysia. 
 
Demam denggi mempunyai spektrum manifestasi klinikal yang sangat luas dengan tahap 
keterukan yang berbeza. Serotaip denggi yang berbeza mungkin punca kepelbagaian 
manifestasi tersebut. Sejak kebelakangan ini, terdapat peningkatan bilangan kes 
manifestasi mata dalam denggi, daripada penyakit yang ringan kepada keadaan yang 
mengancam penglihatan. 
 
Objektif: 
Objektif kajian ini adalah untuk menentukan kelaziman manifestasi ocular di kalangan 
pesakit denggi, untuk menentukan kaitan antara manifestasi mata dan serotaip virus 
denggi yang berbeza dan untuk mengenal pasti peramal manifestasi mata dalam denggi. 
 
Kaedah kajian: 
Ini adalah kajian rentas yang dijalankan di Hospital Selayang, Gombak, Malaysia. 
Seratus tiga puluh lapan pesakit yang di pastikan menghidap demam denggi telah 
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direkrut dari Januari 2017 hingga Januari 2018. Pemeriksaan mata yang lengkap untuk 
setiap pesakit termasuk penilaian ketebalan makula menggunakan mesin Heidelberg 
Spectral Domain Optical Coherence Tomography (OCT). Sampel darah dihantar untuk 
analisa dan identifikasi serotaip virus denggi. Kaedah reverse transcription polymerase 
chain reaction  (RT-PCR digunakan untuk mengenal pasti serotaip denggi DENV-1, 
DENV-2, DENV-3 dan DENV-4. Hasil kajian dianalisa menggunakan Pakej Statistik 
untuk Sains Sosial (SPSS) yang membandingkan manifestasi mata di kalangan serotaip 
denggi yang berbeza. 
 
Keputusan: 
Manifestasi mata diperhatikan pada 18 (13%) pesakit dari kajian ini. Empat belas (10%) 
pesakit mengalami kemerahan mata. Pendarahan sub-konjunktiva adalah penemuan 
paling banyak ditemui melibatkan 14 pesakit di mana 9 (64%) pesakit telah dijangkiti 
oleh DENV-1(p=0.019). Penemuan fundus pula terdapat pada hanya 3 pesakit termasuk 
2 yang melibatkan makula. Seorang pesakit mengalami anterior uveitis dan ia ditemui 
berhubung kait jangkitan DENV-3 (p= 0.014). Umur, jantina, bangsa dan juga keputusan 
darah bukan merupakan peramal signifikan dalam ujian ini (p>0.05). 
 
Kesimpulan: 
Manifestasi mata adalah sangat lazim di kalangan pesakit denggi. Didapati bahawa 
manifestasi mata adalah berhubungkait dengan serotaip denggi yang tertentu. Tiada 
peramal signifikan untuk manifestasi mata denggi yang dikenal pasti dalam kajian ini. 
Kajian lanjut dan yang lebih meluas perlu dijalankan untuk menilai dengan lebih 
terperinci korelasi antara serotaip yang berbeza dengan manifestasi mata yang lain. 
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ABSTRACT 
 
 
Background: 
 
Dengue is the most rapidly spreading mosquito-borne disease in the world causing a 
substantial public health burden in the Western Pacific Region. It is a major cause of 
mortality and morbidity in Malaysia. Malaysia is hyperendemic for dengue, as 
evidenced by simultaneous presence of all four dengue serotypes (DENV-1, DENV-2, 
DENV-3, DENV-4). However, the predominant serotype differs from year to year and 
varies across the different states in Malaysia. Dengue fever has a wide spectrum of 
clinical manifestations with varying degrees of severity. Different dengue serotypes may 
contribute to the variability and severity of manifestations. Over the recent years, there 
has been increasing numbers of cases of ocular manifestations in dengue, from mild self-
limiting presentation to sight threatening conditions.  
 
Objectives: 
The objectives of this study are to determine the prevalence of ocular manifestations in 
dengue patients, to determine the association between ocular manifestations and the 
different serotypes of dengue virus and to identify the predictors of ocular 
manifestations in dengue. 
 
Methods: 
This is a cross-sectional study conducted in Hospital Selayang, Gombak, Malaysia. One 
hundred and thirty eight patients diagnosed with dengue fever were recruited from 
January 2017 to January 2018. Complete ocular examination was done for each patient 
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including assessment of macula thickness using Heidelberg Spectral-Domain Optical 
Coherence Tomography (OCT). Serum blood sample is sent for full blood count and 
dengue serotype. Reverse transcription- polymerase chain reaction (RT-PCR) method 
was used to identify the dengue serotypes DENV-1, DENV-2, DENV-3 and DENV-4. 
Findings were analysed using Statistical Package for Social Sciences (SPSS) comparing 
ocular manifestations among the different dengue serotypes.  
 
Results: 
Ocular manifestations were present in 18 (13%) patients from the study. Fourteen (10%) 
patients had eye redness. Subconjunctival haemorrhage was the commonest eye findings 
seen in 14 patients in which 9 (64%) patients were infected by DENV-1 (p=0.019). 
Fundus findings were present in 3 patients including 2 maculopathy. One patient had 
anterior uveitis and is found to be associated with DENV-3 (p= 0.014)Age, gender, 
ethnicity and full blood count values including platelet level were found not to be 
significant predictors in this study (p>0.05). 
 
Conclusion: 
Ocular manifestations are prevalent amongst dengue patients. There is association 
between  specific dengue serotype with ocular manifestations. There is no significant 
predictors of dengue ocular manifestation identified in this study. Further research and 
larger studies need to be conducted to evaluate correlation between the different 
serotypes with other types of ocular manifestation and its severity. 
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1.1 Epidemiology of dengue fever 
 
Dengue fever is the most rapidly spreading vector borne disease in the world. World 
Health Organization (WHO) estimated 50 million dengue cases occur annually and 
approximately 2.5 billion people live in endemic countries. 
This has turned this disease into a serious public health problem especially in 
tropical and subtropical countries (Teixeira et all, 2002). The dengue incidence in 
Malaysia from year 2000 to 2010 showed increasing trend, with percentage of 
dengue cases and dengue deaths increase by 14% and 8% per year respectively (Md. 
Shahin et al, 2013).  
 
1.2 Dengue classification 
 
The WHO 1997 dengue guideline classified dengue into dengue fever (DF), dengue 
haemorrhagic fever (DHF Grade 1 and 2) and dengue shock syndrome (DHF Grade 
3 and 4). However, this classification is found to have many limitations. Alexander 
et al found that not all dengue shock cases fulfil the DHF criteria (Alexander et al, 
2011). This result became the basis for the revision of the new WHO dengue 
guideline. The WHO 2009 guideline classified dengue according to severity; dengue 
without warning signs, dengue with warning signs (abdominal pain, persistent 
vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, 
increasing haematocrit with decreasing platelets) and severe dengue (dengue with 
severe plasma leakage, severe bleeding, or organ failure). 
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1.3 Dengue virus 
 
The dengue virus (DENV) belongs to the family Flaviviridae, genus Flavivirus and is 
transmitted to humans by Aedes aegypti mosquitoes. It consists of four antigenically 
distinct serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) and each serotype has 
several subtypes or genotypes (Shu et al, 2004; Martina et al, 2009).  All four dengue 
serotypes are found in Malaysia but predominant serotype changes from year to year and 
varies across the different states in Malaysia (Mudin et al, 2015; Ng et al, 2015). 
 
 
1.4 Dengue diagnostic tools 
 
Previously, confirmatory laboratory tests used to diagnose acute DENV infection were 
one or a combination of the three basic laboratory diagnostic methods: DENV isolation, 
detection of viral nucleic acid amplification technology assay by reverse transcription 
polymerase chain reaction (RT-PCR), and serological demonstration of a four-fold or 
greater rise in antibodies (IgM and/or IgG) titre to DENV (De Paula et al, 2004; Chua et 
al, 2011). Recent scientific reports show that in acute DENV infection, the non-
structural protein one (NS1) of the virus could be detected in infected patient's blood 
(Young et al, 2000). This finding led to the development of commercial dengue 
diagnostic test kits based on antigen-capture enzyme-linked immunosorbent assay 
(ELISA) for detection of circulating dengue NS1 antigen in acute dengue infection. 
Multiple studies found that NS1 ELISA test shows higher sensitivity for early dengue 
infection compared to other diagnostic methods such as virus isolation and RT-PCR 
(Kumarasamy et al, 2007; Hang et al, 2009; Osorio et al, 2010). Malaysian Ministry of 
Health (MOH) Clinical Practice Guideline (CPG) for management of dengue infection 
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in adults (3
rd
 edition) recommends dengue rapid combo test or NSI antigen  to be taken 
as soon as dengue is diagnosed. Dengue immunoglobulin M (IgM) is usually positive 
after day 5 to 7 of illness, thus a negative IgM before day 5 to 7 does not exclude dengue 
infection. Malaysian MOH CPG recommends repeating dengue IgM in recovery phase if 
initial dengue IgM is negative, and if repeat sample is still negative, dengue IgG should 
be done for diagnostic confirmation of secondary dengue infection. Reverse 
transcription- polymerase chain reaction (RT-PCR) method is used for dengue 
serotyping and identifying the different dengue serotypes (Johnson et al, 2005; Chien et 
al, 2006) . This test is only available in a few centres in Malaysia (e.g. Institute of 
Medical Research, National Public Health Laboratory, State Public Health Laboratories 
and University Malaya Medical Centre). In our study, the serum sample was sent to 
National Public Health Laboratory.  
 
 
1.5 Dengue ocular manifestations 
 
Ocular manifestations in dengue are relatively rare compared to other clinical 
manifestations. There is limited research in literature on the prevalence of ocular 
manifestations in dengue patients and none published on the prevalence in Malaysia 
(Lim et al, 2004; Kapoor et al, 2006; Chan et al, 2006). This limitation may be due to the 
variable severity of presentation in ocular manifestations whereby most cases are 
asymptomatic or self-limiting, and visual disturbance mostly presents in posterior 
segment involvement (e.g. dengue maculopathy, optic neuropathy) (Bacsal et al, 2007; 
Sanjay et al, 2008). The most common anterior segment manifestation is found to be 
subconjunctival haemorrhage (Kapoor et al, 2006). Several isolated case reports in 
Malaysia have been published over the recent years with maculopathy being more 
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commonly reported (Juanarita et al,  2012; Fhun et al, 2016; Boo et al, 2017, Chuah et 
al, 2017). Optical coherence tomography (OCT) is a reliable tool  for diagnostic and 
prognostic purposes in dengue maculopathy (Teoh et al, 2010). Fundus fluorescein 
angiography (FFA) is useful for diagnosis of vein occlusion and vasculitis (Bacsal et al, 
2007; Quek et al, 2009, Gupta et al, 2009). The outcome of ocular manifestations in 
dengue varies depending on its severity from self-limiting to permanent visual loss in 
severe cases. 
 
 
1.6 Rationale of study 
 
 
There is limited literature on association of serotype specific dengue virus infection with 
clinical manifestations and its severity. Halsey et al found that specific clinical 
manifestation are often represented by an individual DENV serotype. The study showed 
DENV-3 had a higher prevalence of musculoskeletal and gastrointestinal manifestations, 
while DENV-4 patients had a higher prevalence of respiratory and cutaneous 
manifestations (Halsey et al, 2012). In a study conducted by Yung et al, DENV-1 
patients were found to have higher risk of developing DHF compared to patients with 
DENV-2 or DENV-3. DENV-1 cases were more likely to present with red eyes while 
DENV-2 cases were more likely to develop joint pain (Yung et al, 2015). DENV-2 was 
also associated with more severe infection ( Vaughn et al, 2000; Balsameda et al, 2006). 
Based on these literatures, we think that there will be an association between ocular 
manifestations and dengue serotypes. However, to our knowledge, there is no study done 
to assess the association of ocular manifestations with dengue serotypes. Thus, our study 
aims to evaluate prevalence of ocular manifestations in dengue patients, to determine the 
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association between ocular manifestation and the different serotypes of DENV and to 
identify the predictors of ocular manifestations in dengue which may help in more 
specific and thorough screening of dengue ocular manifestations in the future. 
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2.0 STUDY OBJECTIVES 
 
2.1 General Objective 
To evaluate ocular manifestations and its predictors in dengue patients. 
 
 
 
2.2 Specific Objectives 
2.2.1. To determine the prevalence of ocular manifestations in patients diagnosed with  
dengue fever. 
2.2.2. To determine the association between ocular manifestations and the different 
serotypes of dengue virus. 
2.2.3. To identify the predictors of ocular manifestations in dengue patients. 
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3.3 ABSTRACT 
 
Objectives: 
The objectives of this study are to determine the prevalence of ocular manifestations in 
patients diagnosed with dengue fever, to determine the association between dengue 
ocular manifestations and the different serotypes of dengue fever and to identify 
predictors of ocular manifestations in dengue patients. 
 
Methods: 
A cross sectional study was conducted between January 2017 and January 2018 
involving patients with confirmed dengue fever who were admitted to Hospital 
Selayang, Malaysia. Detailed information regarding clinical signs and symptoms was 
collected and complete ophthalmic examination was done. Evaluation of macular 
thickness was conducted using Heidelberg Spectral Domain Optical Coherence 
Tomography (OCT). Blood samples were collected and sent for full blood count and 
dengue virus serotyping. Statistical analysis was done using Statistical Package for the 
Social Science (SPSS Inc Version 24).   
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Results: 
A total of 138 patients diagnosed with dengue fever were included into the study. The 
mean age was 32.8 years (SD 13.57) and 56.5% were females. The racial distribution 
was predominantly Malay (55.1%). Fourteen (10%) patients had eye redness but only 1 
(0.7%) patient had associated blurring of vision. Ocular manifestations were present in 
18 (13%) patients. Subconjunctival haemorrhage was the commonest eye findings seen 
in 14 (10.1%) patients in which 9 (64%) patients were infected by DENV-1 (p= 0.019). 
Fundus findings were present in 3 (2.1%)  patients including 2 (1.4%) maculopathy. One 
(0.7%) patient had anterior uveitis and was infected by DENV-3 (p= 0.014). The clinical 
and laboratory predictors of ocular manifestation evaluated in this study were age, 
gender, ethnicity, and full blood count but none were found to be significant (p > 0.05). 
 
 
Conclusion: 
The prevalence of ocular manifestation in patients diagnosed with dengue fever was 
13% in our study. There was significant association between DENV-1 infection with 
subconjunctival haemorrhage while infection with DENV-3 was found to be associated 
with anterior uveitis. There were no other significant demographic or laboratory 
predictors of dengue ocular manifestations found in our study. 
 
 
 
 
